Palvella Therapeutics PVLA Insider Ownership

Updated Oct 10, 2026

Over the past year, PVLA insiders bought $849,974 of stock (6.84K shares) and sold $9.72 million (75.14K shares) on the open market.

• Counted by insider, open-market buying of PVLA stock in the past 12 months came from 2 insiders and selling from 3 insiders.
• Among Palvella Therapeutics' insiders, George M. Jenkins (Director) was the largest open-market buyer over the past 12 months, purchasing $549,974 of stock (4.45K shares), most recently on March 30, 2026.
• Meanwhile, the largest open-market sales of PVLA in the past 12 months were by Kathleen Goin (Chief Operating Officer), totaling $5.51 million (47.32K shares), most recently on September 16, 2026.
• In transactions other than open-market trades, Palvella Therapeutics insiders acquired 48.63K shares through option exercises and conversions over the past 12 months.
• Business Quant data puts insider holdings in PVLA at 261.65K shares across insiders' latest Form 4 filings, or 1.82% of the 14.4Mn shares outstanding.
• Palvella Therapeutics insiders hold 248.14K shares directly (94.83% of their total) and 13.52K shares (5.17%) indirectly, through entities such as trusts and partnerships.
• Business Quant counts 5 insiders with holdings in Palvella Therapeutics stock, among the officers, directors and 10% owners who have filed a Form 4 in the past two years.
• PVLA's largest insider holders by reported holdings are George M. Jenkins (Director, 173.63K shares), Elaine J. Heron (Director, 47.81K shares) and BVF Partners L.P. (38.96K shares).
• George M. Jenkins holds 66.36% of the combined insider position in Palvella Therapeutics.
• Over the past 12 months, 12 insiders reported transactions in Palvella Therapeutics stock in 30 Form 4 filings.
• Insider figures for PVLA include Form 4 filings through September 18, 2026.